As of today (2024-04-18), Santen Pharmaceutical Co's share price is $9.4339.
Santen Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.31. Hence, Santen Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 7.20.
The historical rank and industry rank for Santen Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SNPHY'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.53 Med: 19.4 Max: 140.19
Current: 7.87
During the past 13 years, Santen Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 140.19. The lowest was 7.53. And the median was 19.40.
Santen Pharmaceutical Co's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $0.62.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.31.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Santen Pharmaceutical Co was 69.60% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -1.30% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.70% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 12.60% per year.
During the past 13 years, Santen Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 55.90% per year. The lowest was -27.30% per year. And the median was 13.35% per year.
Santen Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Santen Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Santen Pharmaceutical Co Annual Data
|
|
Trend |
Mar14 |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
20.42 |
18.62 |
15.71 |
10.67 |
11.79 |
|
Santen Pharmaceutical Co Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.65 |
11.79 |
12.52 |
10.93 |
7.44 |
Competitive Comparison
For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Santen Pharmaceutical Co Price-to-Operating-Cash-Flow Distribution
For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Santen Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.
Santen Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation
Santen Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 9.4339 | / | 1.311 |
| = | 7.20 |
Santen Pharmaceutical Co's Share Price of today is $9.4339.
Santen Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.31.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Santen Pharmaceutical Co (Santen Pharmaceutical Co) Business Description
Traded in Other Exchanges
Address
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.
Santen Pharmaceutical Co (Santen Pharmaceutical Co) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SNPHY has been successfully added to your